role of microrna in the prediction of breast cancer

This paper delves into the ground-breaking role of microrna in forecasting cancer, focusing particularly on breast cancer. micrornas, tiny non-coding rna molecules, govern gene expression and have surfaced as encouraging biomarkers for cancer prognosis. traditional approaches to breast cancer forecasting, like mammography and genetic testing, come with constraints in accuracy and sensitivity. microrna-dependent prognostication techniques present benefits, such as stability in bodily fluids, tissue-specific expression patterns, and the potential for non-invasive testing. these techniques can enhance precision, sensitivity, and specificity, resulting in timely detection and personalized treatment plans. despite the promising outlook for microrna in cancer prognosis, obstacles like standardization of detection techniques and ethical dilemmas require attention. scopus, pubmed and, web of science databases were used, and articles were extracted and reviewed using the keywords microrna, breast cancer, prediction. the paper concludes that microrna is poised to assume a pivotal role in the timely identification and efficient management of cancer, heralding a new age of tailored medicine.